Strides Pharma Science, TLC partner to launch Liposomal Amphotericin B

27 May 2021 Evaluate

Strides Pharma Science and Taiwan-based specialty pharmaceutical firm TLC have partnered to launch Liposomal Amphotericin B, a drug used in the treatment of mucormycosis (black fungus), in India. The Central Drugs Standard Control Organization (CDSCO) has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50mg in India for immediate importation per approved usage and indication.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

883.45 -3.65 (-0.41%)
11-Dec-2025 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.00
Dr. Reddys Lab 1262.05
Cipla 1505.15
Zydus Lifesciences 924.30
Lupin 2070.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×